| UHC Medicare Advantage | Molecular Pathology/Molecular Diagnostics/Genetic Testing – Medicare Advantage Medical Policy | 2026-09-01 |
| UHC Medicare Advantage | Neurologic Services and Procedures – Medicare Advantage Medical Policy | 2026-09-01 |
| UHC Medicare Advantage | Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart Disease – Medicare Advantage Medical Policy | 2026-09-01 |
| UHC Medicare Advantage | Orthopedic Procedures, Devices, and Products – Medicare Advantage Medical Policy | 2026-09-01 |
| UHC Medicare Advantage | Osteopathic Manipulations (OMT) – Medicare Advantage Medical Policy | 2026-09-01 |
| UHC Medicare Advantage | Pain Management – Medicare Advantage Medical Policy | 2026-09-01 |
| UHC Medicare Advantage | Percutaneous Coronary Interventions – Medicare Advantage Medical Policy | 2026-09-01 |
| UHC Medicare Advantage | Percutaneous Ventricular Assist Device – Medicare Advantage Medical Policy | 2026-09-01 |
| UHC Medicare Advantage | Pharmacogenomics Testing – Medicare Advantage Medical Policy | 2026-09-01 |
| UHC Medicare Advantage | Platelet Rich Plasma Therapies – Medicare Advantage Medical Policy | 2026-09-01 |